Risk

  • Although primary cardiac tumors are rare (<0.01%), myxoma is the most common type (50%).

  • 75% develop in LA, with most attached to the interatrial septum.

  • Rarely develop in ventricles.

  • More common in females (70%).

Perioperative Risks

  • May be friable and may embolize (30–40% of pts)

  • LV- or RV-inflow obstruction with resultant hypotension

  • May simulate pulm Htn and/or constrictive pericarditis physiology

Worry About

  • Hypotension due to obstruction of ventricular inflow and/or incompetence of tricuspid (right) or mitral (left) valve, may be positional.

  • Tumor flips on a stalk across valves, causing stenotic and/or incompetent symptoms.

  • RV hypertrophy can occur because of longstanding left ventricular–inflow obstruction.

  • There is the possibility of pulm or systemic embolization.

Overview

  • Is a true neoplasm and distinct from a thrombus

  • Usually polypoid, pedunculated with a 1–2 cm stalk, and round with smooth margins

  • Typically grows very slowly before the patients becomes symptomatic (10–20 y)

Etiology

  • Typically arises from the endocardium and rarely extends deeper.

  • Polyhedral cells with small nuclei are separated by an afibrillar, eosinophilic myxomatous stroma that is predominantly a mucopolysaccharide.

  • Although benign, this tumor rarely can undergo malignant degeneration.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here